Interim infection control guidance for non-hospital based inpatient and residential addiction treatment providers amidst the COVID-19 pandemic. Issued 4/9/20. Updated 5/12/21.

Best practices in an Opioid Treatment Program during COVID-19. April 19, 2021.

Description of medical services covered within the per diem, and those outside of the per diem in bedded Crisis, Inpatient, and Residential Programs.

OASAS is pleased to be working with the Institute on Trauma and Trauma-Informed Care to provide a follow-up session to the virtual office hours we offered...

Guidance regarding COVID-19 education of clients and vaccination reporting status in OMH/OASAS faciltiies.

Overview and updates on the current statutory, regulatory, clinical, and reimbursement changes that were put into place since the beginning of the pandemic pursuant to Executive Order...

This guidance provides information on SARS-CoV-2 (COVID-19) POC Ag testing for New York State (NYS) Office of Addiction Services and Supports (OASAS) licensed, funded, and...

Guidance and best practices for long-term maintenance with medications for patients with Opioid Use Disorder (OUD) from the OASAS Medical Advisory Panel.

Guidance addressing the appropriateness of OASAS program participants who become involved in work activities that are not directly related to their treatment and rehabilitation.